首页> 外文期刊>Animal Biotechnology >Human Ubiquitin C Promoter Based Expression of Erythropoietin in CHO K1 Cell Lines: A Simple Transfectants Screening Approach
【24h】

Human Ubiquitin C Promoter Based Expression of Erythropoietin in CHO K1 Cell Lines: A Simple Transfectants Screening Approach

机译:基于人泛素C启动子的促红细胞生成素在CHO K1细胞系中的表达:一种简单的转染子筛选方法

获取原文
获取原文并翻译 | 示例
           

摘要

Erythropoietin (EPO), a glycoprotein hormone that regulates the production of erythrocytes in the human body, is of clinical importance in the treatment of anemia. Low expression levels of this recombinant hormone and time-consuming screening methods have made its commercial production expensive. Cloning of human EPO gene in a shuttle vector pUB6/V5-HisB driven by human ubiquitin C promoter and its transfection in CHO K1 cell lines by electroporation resulted in a moderate level of EPO expression. The limiting-dilution screening method required several months to obtain high expression stable transfectants but needed only short duration for selection in contrast to the present screening strategy. The supernatants of stably transfected cells were found to be biologically active by in vitro erythroid cluster forming activity.
机译:促红细胞生成素(EPO)是一种调节人体中红细胞产生的糖蛋白激素,在贫血的治疗中具有重要的临床意义。这种重组激素的低表达水平和费时的筛选方法使其商业生产昂贵。在人泛素C启动子驱动的穿梭载体pUB6 / V5-HisB中克隆人EPO基因,并通过电穿孔将其转染到CHO K1细胞系中,导致EPO表达水平适中。限制性稀释法筛选方法需要几个月来获得高表达稳定的转染子,但是与目前的筛选策略相比,仅需要很短的筛选时间。稳定转染的细胞的上清液通过体外类红素簇形成活性被发现具有生物活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号